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ABSTRACT
The functional association between intronic miRNAs
and their host genes is still largely unknown. We
found that three gene loci, which produced miR-26a
andmiR-26b,wereembeddedwithinintronsofgenes
coding for the proteins of carboxy-terminal domain
RNA polymerase II polypeptide A small phosphat-
ase (CTDSP) family, including CTDSPL, CTDSP2
and CTDSP1. We conducted serum starvation-
stimulation assays in primary fibroblasts and
two-thirds partial-hepatectomies in mice, which
revealed that miR-26a/b and CTDSP1/2/L were
expressed concomitantly during the cell cycle
process. Specifically, they were increased in quies-
cent cells and decreased during cell proliferation.
Furthermore, both miR-26 and CTDSP family mem-
bers were frequently downregulated in hepato-
cellular carcinoma (HCC) tissues. Gain- and
loss-of-function studies showed that miR-26a/b
and CTDSP1/2/L synergistically decreased the
phosphorylated form of pRb (ppRb), and blocked
G1/S-phase progression. Further investigation
disclosed that miR-26a/b directly suppressed the
expression of CDK6 and cyclin E1, which resulted
in reduced phosphorylation of pRb. Moreover,
c-Myc, which is often upregulated in cancer cells,
diminished the expression of both miR-26 and
CTDSP family members, enhanced the ppRb
level and promoted the G1/S-phase transition.
Our findings highlight the functional association
of miR-26a/b and their host genes and provide
new insight into the regulatory network of the
G1/S-phase transition.
INTRODUCTION
MicroRNAs (miRNAs) belong to a class of endogenously
expressed, small non-coding RNAs that cause translation-
al repression and/or mRNA destabilization by binding
to the 30-untranslated regions (30-UTRs) of the target
mRNAs (1). Approximately 40% of all miRNAs are
located within intronic regions of protein-coding tran-
scriptional units (TUs) (2). Analysis of 175 human
miRNAs across 24 different human organs reveals that
the expression of intronic miRNAs largely coincides
with the transcription of their host TUs (3), indicating
that the intronic miRNAs and their host genes may be
co-regulated and are generated from a common precursor
transcript.
Emerging evidence suggests that intronic miRNAs may
be functionally associated with their host genes. Few
reports suggest that there is an antagonizing effect of the
intronic miRNA on the function of its host gene, as with
miR-218 (4) and miR-10 (5,6). The secreted Slit ligands
and their Robo receptors constitute a Slit–Robo signaling
pathway that controls the directed migration of neurons
and vascular endothelial cells during embryonic develop-
ment. miR-218 is localized in the intron of the Slit gene,
and similar expression patterns are observed between
miR-218 and Slit in different tissues. Furthermore,
miR-218 inhibits the expression of Robo1 and Robo2,
which generates a negative feedback loop in response to
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‘ﬁne-tuning’ of the Slit–Robo pathway (4). Another
example of miRNAs associating with their host genes
are the miR-10 family members, whose gene loci are
retained within the Hox clusters that encode for develop-
mental regulators. Interestingly, Hox transcripts are
targets of the miR-10 family members in several species
(5,6). However, there may be a synergistic effect of
miRNA with its host gene. miR-33a/b act in concert
with their SREBP (sterol regulatory element-binding
protein) host genes to control cholesterol homeostasis
(7–10). miR-208a/b and their Myh6/7 host genes cooper-
ate to govern myosin expression and muscle performance
(11). The miR-106–25 cluster and its host gene MCM7
transforms cells synergistically (12). miR-151 and the
host gene FAK work together to enhance the motility
and spreading of hepatocellular carcinoma (HCC) cells
(13). An extensive investigation of the functional associ-
ation between intronic miRNAs and their host genes will
help to disclose the elaborate regulatory network of
cellular activity.
Over the course of evolution, the genomic loci of
miR-26a and miR-26b have been localized to the introns
of genes coding for the proteins of carboxy-terminal
domain RNA polymerase II polypeptide A small phos-
phatase (CTDSP) family. However, the functional asso-
ciation of miR-26 with CTDSP family members and
the biological signiﬁcance of this association remain
unknown. Herein, we show that miR-26 family members
are expressed concomitantly with their host genes in
physiological and pathological conditions. We further
disclose that miR-26a/b and their host genes cooperate
to block the G1/S-phase transition by synergistically
activating the pRb protein. Our ﬁndings highlight the
functional association of miR-26a/b and their host genes
and the potential implication of this association in physio-
logical and pathological processes.
MATERIALS AND METHODS
Cell lines and human tissue specimens
Cancer cell lines, which were derived from the liver
(MHCC-97L, HepG2 and Huh7), lung (95D), breast
(MCF7) and cervix (HeLa), were maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM, Hyclone,
Logan, UT, USA) supplemented with 10% fetal bovine
serum (FBS, HyClone, Thermo Fisher Scientiﬁc, Austria).
Primary ﬁbroblasts were isolated from human neonatal
foreskin using an optimized enzymatic dissociation pro-
cedure (14) and grown in RPMI 1640 medium (Hyclone)
supplemented with 10% FBS, penicillin and streptomycin.
Normal liver tissues were collected from patients under-
going resection of hepatic hemangiomas, and paired HCC
and adjacent non-tumor liver tissues were obtained from
patients undergoing HCC resection at the Cancer Center
of Sun Yat-sen University. Both tumor and non-tumor
tissues were histologically conﬁrmed. No local or
systemic treatments had been conducted before the oper-
ations. Informed consent was obtained from each patient,
and the study was approved by the Institute Research
Ethics Committee at the Cancer Center of Sun Yat-sen
University.
Two-thirds partial hepatectomy in mice
Eight- to twelve-week-old male C57BL/6 mice were used.
Two-thirds of the liver was surgically removed under
chloral hydrate anesthesia as previously described (15).
All experimental procedures involving animals were in
accordance with the Guide for the Care and Use of
Laboratory Animals (NIH publications Nos. 80-23,
revised 1996) and were performed according to the insti-
tutional ethical guidelines for animal experiments.
RNA oligoribonucleotides and plasmids
hsa-miR-26a/b (Pre-miR miRNA Precursor Product, cat.
AM17100) and NC (Pre-miR Negative Control #2, cat.
AM17111) were purchased from Applied Biosystems
(Foster City, CA, USA). Other RNA oligoribonucleotides
(Supplementary Table S1) were obtained from
Genepharma (Shanghai, P.R. China). The siRNAs target-
ing human CDK6 (GenBank accession no. NM_001259),
CCNE1 (NM_001238), c-Myc (NM_002467), CTDSP1
(NM_021198 and NM_182642), CTDSP2 (NM_005730)
and CTDSPL (NM_005808 and NM_001008392) tran-
scripts were designated as siCDK6, siCCNE1, siMyc,
siCTDSP1, siCTDSP2 and siCTDSPL, respectively. The
anti-miR-26, with a sequence complementary to mature
miR-26b, was a 20-O-methyl-modiﬁed oligoribonucleotide.
The anti-miR-C, which is non-homologous to any human
genome sequences, was used as a negative control for
anti-miR-26.
The vectors used (details in Supplementary Materials
and Methods) included ﬁreﬂy luciferase reporter
plasmids that contained a wild-type or mutant 30-UTR
segment of human CDK6 or CCNE1, and pc3-gab-
CDK6, pc3-gab-CCNE1, pc3-gab-c-Myc, pc3-gab-
CTDSP1, pc3-gab-CTDSP2 and pc3-gab-CTDSPL,
which expressed CDK6, CCNE1, c-Myc, CTDSP1,
CTDSP2 and CTDSPL, respectively.
Cell transfection
RNA oligos were transfected using Lipofectamine
RNAiMAX (Invitrogen, Carlsbad, CA, USA). A ﬁnal
concentration of 50nM duplex or 200nM miRNA inhibi-
tor was used unless indicated. RNA transfection efﬁciency
is  70–80% (16), and overexpression of a miRNA mimic
persists for at least 4 days (17). TurboFect
TM in vitro
Transfection Reagent (Fermentas, Hanover, MD, USA)
was used for transfection of HepG2 with pc3-gab or
pc3-gab-c-Myc. Other transfection of plasmid DNA
with or without RNA oligos was performed using
Lipofectamine 2000 (Invitrogen).
Cell cycle analysis
All cell cycle analyses were performed using a detergent-
containing hypotonic solution (Krishan’s reagent) and
ﬂuorescence-activated cell sorting (FACS) (Gallios,
Beckman Coulter, Miami, FL, USA) as previously
4616 Nucleic Acids Research, 2012,Vol.40, No. 10reported (18). Nuclear debris and overlapping nuclei were
gated out.
Luciferase reporter assay
MHCC-97L cells grown in a 48-well plate were
co-transfected with 10ng of ﬁreﬂy luciferase reporter
comprising a wild-type or mutant 30-UTR of the target
gene, 2ng of pRL-TK (Promega, Madison, WI, USA)
and 10nM of RNA oligoribonucleotides. A luciferase
assay was performed as previously reported (16). The
pRL-TK vector that provided the constitutive expression
of Renilla luciferase was used as an internal control to
correct for the differences in transfection and harvest
efﬁciencies. Transfection was performed in duplicate
and was repeated at least three times in independent
experiments.
Analysis of gene expression
Semiquantitative RT–PCR and real-time quantitative
RT–PCR (qPCR) were performed to evaluate the RNA
level. Expression of CTDSP1/2/L was quantiﬁed by
THUNDERBIRD SYBR qPCR Mix (QPS-201,
TOYOBO, Japan), using b-actin and GAPDH as refer-
ence genes. Expression of miR-26a/b was quantiﬁed
using the miRCURY LNA Universal RT microRNA
PCR system (Exiqon, Vedbaek, Denmark) when b-actin
and GAPDH were used as internal standards, or by a
TaqMan MicroRNA Assay kit (Applied Biosystems,
Foster City, CA, USA) when U6B was used as reference.
Western blot and immunohistochemical staining were
performed to detect the protein level (details in
Supplementary Materials and Methods).
Bioinformatic tools and statistical analysis
The databases used for bioinformatic analysis are
described under Supplementary Materials and Methods.
To search for miRNA families that reside within the
introns of protein families, miRNA and protein families
were ﬁrst extracted from the miRBase and Ensembl
Genome Browsers, respectively. The sequences of
miRNA family members were mapped to hosting TUs
using the Ensembl Genome Browser. We only considered
those host genes whose intron or exon sequences
overlapped the miRNA and were transcribed on the
same strand as miRNA.
Data were expressed as the mean±standard error of
the mean (SEM) from at least three independent experi-
ments. Unless otherwise noted, the differences between
groups were analyzed using Student’s t-test when only
two groups were compared and using one-way ANOVA
when more than two groups were compared. Correlation
was explored by Spearman’s correlation coefﬁcient. All
statistical tests were two-sided. A P<0.05 was considered
statistically signiﬁcant. All analyses were performed using
the GraphPad Prism program (GraphPad Software Inc.,
San Diego, CA, USA).
RESULTS
miR-26 family members are expressed concomitantly with
their host genes in physiological and pathological
conditions
Since the birth and death rates of miRNA genes are rather
high over the course of evolution (19), the co-localization
of some miRNAs and their host genes may be a coinci-
dence. However, if a miRNA family always resides within
the gene loci of a protein family, they are more likely
to be physiologically relevant. To identify miRNAs
that exhibit a functional association with their host
genes, we ﬁrst mapped the gene loci of miRNA families
to hosting TUs. Among 108 miRNA families with
at least two members that have been identiﬁed in
human, 13 of them were mapped to the introns of
protein families (Supplementary Table S2). Except for
miR-128, miR-506, miR-548 and miR-1233 families,
the colocalization of the other nine miRNA families
with protein-coding genes has been previously noted
(3–7,9–11,20,21). Notably, miR-26, miR-103, miR-33
and miR-153 family members displayed a perfect
one-to-one colocalization with the members of their host
protein family (Table 1).
The miR-26 family comprises miR-26a and miR-26b;
they are transcribed from three genomic loci, miR-26a-1,
miR-26a-2 and miR-26b, which reside in the introns of
genes coding for the CTDSPL, CTDSP2 and CTDSP1
proteins, respectively. The basic arrangement of these
miRNAs in the CTDSP1/2/L genes has remained con-
stant throughout vertebrate evolution (Supplementary
Figure S1). It has been reported that CTDSPL
dephosphorylates the phosphorylated form of pRb
(ppRb) and thereby presumably leads to the arrest of
the cell cycle at the G1/S boundary (22). Furthermore,
expression of miR-26a causes increased G1-cells (23–25).
More importantly, among the predicted targets of
miR-26a/b, we found an enrichment of G1/S transition-
related genes (3.9-fold overrepresentation, P=0.0184;
Supplementary Table S3).
Based on the above pieces of evidence, we ﬁrst examined
whether miR-26a/b and CTDSP1/2/L were expressed con-
comitantly during the cell cycle process using a serum
starvation–stimulation assay. Human primary ﬁbroblasts
were serum deprived for 48h and stimulated to induce
S-phase entry by serum re-addition. The cells were
synchronized in G0-phase by serum deprivation. Within
4h after serum addition, the cells remained in G1-phase,
whereas a large proportion of cells entered S-phase at 16h
and progressed to G2/M-phase at 24h (Figure 1A). The
expression of miR-26a/b and CTDSP1/2/L increased after
serum deprivation, when the cell cycle was arrested at
G0-phase, and decreased quickly after serum stimulation
(Figure 1B, Supplementary Figure S2A). Furthermore,
miR-26a/b and CTDSP1/2/L displayed a similar trend
of expression over time (Figure 1B, Supplementary
Figure S2A). To conﬁrm the ﬁndings from the in vitro
study, we conducted the two-thirds partial hepatectomy
in mice, a physiological liver regeneration model that is
often used to study the cell cycle in vivo. It has been
showed that the majority of the hepatic cells were
Nucleic Acids Research, 2012,Vol.40, No. 10 4617undergoing proliferation around 36h post-hepatectomy
(15,26,27). Interestingly, we found that the expression
of miR-26a/b and CTDSP1/2/L coordinately reduced
at 24h and 36h post-hepatectomy, and began to
elevate around 48h, once cellular proliferation declined
(Figure 1C, Supplementary Figure S2B). Furthermore,
miR-26 and CTDSP family members were frequently
down-regulated in human HCC tissues (Figure 2A,
Supplementary Figure S3A), and a similar expression
pattern was observed between miR-26a and miR-26b
Figure 1. miR-26a/b are expressed concomitantly with CTDSP1/2/L under physiological conditions. (A) FACS analysis of the cell cycle distribution
of human primary ﬁbroblasts. The percentages of G0/G1-, S- and G2/M-cells are indicated in each histogram. (B) Analysis of mature miR-26a/b and
CTDSP1/2/L expression in human primary ﬁbroblasts by quantitative real-time PCR (qPCR). For (A and B), cells were serum deprived for 48h,
then stimulated to enter S-phase by serum re-addition. Unsync, exponentially growing cells without serum deprivation; 0h denotes serum-deprived
cells at the time point when serum was re-added; 2h, 4h, 16h and 24h denote cells in the indicated time points after serum re-addition. (C) Analysis
of mature miR-26a/b and CTDSP1/2/L expression in mouse liver by qPCR. 0h denotes two-thirds of the liver that was surgically removed; 24h,
36h, 48h and 72h denote livers that were obtained at the indicated time points after partial hepatectomy. The expression levels of miR-26a/b and
CTDSP1/2/L were normalized to b-actin.
Table 1. Perfect one-to-one colocalization between miRNA and protein family members
miRNA family miRNA family ID
a Protein family ID
b Colocalization of miRNA and
protein family members
miR-26 MIPF0000043 ENSFM00500000269811 hsa-miR-26a-1—CTDSPL
hsa-miR-26b—CTDSP1
hsa-miR-26a-2—CTDSP2
miR-103 MIPF0000024 ENSFM00260000050538 hsa-miR-103-2—PANK2
hsa-miR-103-1—PANK3
hsa-miR-107—PANK1
miR-33 MIPF0000070 ENSFM00250000001438 hsa-miR-33a—SREBF2
hsa-miR-33b—SREBF1
miR-153 MIPF0000050 ENSFM00260000050522 hsa-miR-153-1—PTPRN
hsa-miR-153-2—PTPRN2
amiRNA family ID was derived from miRBase (release 16.0).
bProtein family ID was obtained from Ensembl Genome Browser (release 60).
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their respective host genes (Figure 2B, Supplementary
Figure S3B).
Expression of miR-26a/b can be suppressed by
c-Myc in lymphoma cells (25,28). We also found that
c-Myc silencing increased endogenous miR-26a/b and
CTDSP1/2/L levels in HCC cells (Figure 3A), whereas
overexpression of c-Myc downregulated the expression
of miR-26a/b and CTDSP1/2/L (Figure 3B).
These results indicate that miR-26a/b and CTDSP1/2/L
maybe co-regulatedinbothphysiological andpathological
processes.
Figure 2. miR-26a/b are expressed concomitantly with CTDSP1/2/L in a pathological condition. (A) Analysis of mature miR-26a/b and CTDSP1/2/
L expression in 32 paired HCC and adjacent non-tumor tissues by qPCR. T, HCC tissue and N, adjacent non-cancerous tissue. The y-axis indicates
the relative level of miR-26a/b and CTDSP1/2/L. The boxes represent the interquartile range (25–75th centiles). The horizontal line inside the box
indicates the median. The vertical whiskers extend to the maximum and minimum values. (B) The correlation between expression levels of miR-26a/b
and their respective host genes in 32 paired HCC and adjacent non-tumor tissues. The expression status of miR-26a/b and CTDSP1/2/L is shown in
a log 2 scale. For (A and B), statistical analysis was performed by Wilcoxon matched-pairs signed-ranks test and Spearman’s correlation coefﬁcient,
respectively. The expression levels of miR-26a/b and CTDSP1/2/L were normalized to b-actin.
Figure 3. The expression of miR-26a/b and CTDSP1/2/L is co-regulated by c-Myc. (A) Effect of c-Myc silencing on mature miR-26a/b and
CTDSP1/2/L expression in HepG2 cells. Forty-eight hours after transfection with 20nM indicated RNA duplex, cells were analyzed by qPCR.
NC, negative control; siMyc, siRNA targets c-Myc. (B) Effect of c-Myc overexpression on mature miR-26a/b and CTDSP1/2/L levels in HepG2
cells. Cells were transfected with empty pc3-gab vector (indicated as EGFP) or pc3-gab-c-Myc (Myc) for 48h, then subjected to qPCR.
The expression levels of miR-26a/b and CTDSP1/2/L were normalized to b-actin. *P<0.05; **P<0.01.
Nucleic Acids Research, 2012,Vol.40, No. 10 4619miR-26a/b function synergistically with their host genes
to block G1/S transition
Next, we evaluated the potential roles of miR-26a/b and
their host genes in the regulation of G1/S transition and
determined the functional signiﬁcance of their association.
Overexpression of either miR-26a or miR-26b resulted in a
marked accumulation of the G1-population in different
cancer cell lines derived from the liver (MHCC-97L,
HepG2 and Huh7), lung (95D), breast (MCF7) and
cervix (HeLa) (Figure 4A, Supplementary Figure S5),
indicating a ubiquitous role for miR-26a/b in cell cycle
control. Serum starvation–stimulation assays further
revealed that most of the miR-26a/b-transfectants
remained in G1-phase (Figure 4B), while a large propor-
tion of NC-transfected cells already entered S-phase after
serum re-addition, suggesting that miR-26a/b can block
G1/S transition.
To conﬁrm the results from the gain-of-function study,
loss-of-function analysis was performed using anti-miR-
26, which could knockdown the expression of miR-26a
and miR-26b (Supplementary Figure S6). Compared
with the control group (anti-miR-C), transfection of
anti-miR-26 only caused a slight decrease in G1-cells
(Figure 4C), which might be explained by the low basal
level of miR-26 in these cells (Supplementary Figure S7).
Thus, we evaluated the effect of miR-26 inhibition using a
c-Myc-knockdown model in which c-Myc silencing caused
elevated endogenous miR-26a/b (Figure 3A). As shown in
Figure 4C, knockdown of c-Myc resulted in an increase in
the G1-population, whereas this effect was attenuated
when miR-26a/b was inhibited by anti-miR-26.
Figure 4. miR-26a/b and CTDSP1/2/L regulate G1/S transition. (A) miR-26a/b overexpression caused accumulation of G1-population. The per-
centage of the G1-population is indicated within each histogram. (B) miR-26a/b overexpression blocked S-phase entry upon serum stimulation.
NC- or miR-26a/b-transfectants were serum-deprived for 48h, followed by serum re-addition, and then were harvested at the indicated time points.
The time point when serum was re-added was set as 0h. (C) Inhibition of miR-26 promoted G1/S transition in c-Myc-knockdown cells. HepG2 cells
were co-transfected with siMyc (20nM) and anti-miR-26 (200nM), followed by FACS analysis. The NC and anti-miR-C were used as the negative
controls for siMyc and anti-miR-26, respectively. (D) Expression of CTDSP family members resulted in G1-arrest. The 95D cells were transfected
with empty pc3-gab vector (EGFP), pc3-gab-CTDSP1, pc3-gab-CTDSP2, pc3-gab-CTDSPL or the mixture of CTDSP1, CTDSP2 and CTDSPL
expressing vectors as indicated. (E) Knockdown of CTDSP family members promoted G1/S progression in HepG2 cells. Cells were transfected with
50nM of siCTDSP1, siCTDSP2, siCTDSPL or a mixture of all three siRNA (16.7nM each). In (A) and (C–E), nocodazole (40ng/ml) was added
32h after transfection, and the cells were cultured for an additional 16h before harvest. ns, not signiﬁcant; **P<0.01; ***P<0.001.
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the cell cycle at G1-phase by dephosphorylating ppRb, the
effect of the other CTDSP family members on the cell
cycle is still unknown. Therefore, we examined whether
all host genes of miR-26a/b play a regulatory role in
G1/S transition. Expression of either of CTDSP1/2/L
induced G1-arrest (Figure 4D), whereas silencing either
of them promoted G1/S progression (Figure 4E).
Furthermore, the effect of triple-overexpression or
-knockdown of CTDSP1/2/L was more pronounced
than single-expression or -knockdown of either one
(Figure 4D and E).
We further determined whether a synergistic effect
exists between miR-26a/b and their host genes in the
context of cell cycle regulation. The G1-arrest was
more evidenced when miR-26a/b and CTDSP1/2/L were
co-expressed (Figure 5A). Consistently, simultaneous
suppression of miR-26a/b and their host genes resulted
in a more pronounced G1/S progression in siMyc-
transfectants (Figure 5B).
Collectively, these data implicate that miR-26a/b can
function synergistically with their host genes to block
G1/S transition.
miR-26a/b and their host genes block G1/S transition by
synergistically activating the pRb protein
We then explored the molecular mechanisms responsible
for the observed function of miR-26a/b and their host
genes. The predicted targets of miR-26a/b included four
G1/S transition-related genes, CDK6, cyclin E1, cyclin D2
and cyclin E2 (Supplementary Table S3), which are crucial
components of the cell cycle that initiate G1/S progres-
sion. Since cyclin D2 and cyclin E2 are the known
targets of miR-26 (24), we focused on CDK6 and cyclin
E1. We identiﬁed one putative miR-26-binding site
in the 30-UTR of CCNE1 and two sites in the 30-UTR
of CDK6 (Supplementary Figure S8) using TargetScan.
A dual-luciferase reporter system revealed that
transfection of miR-26a/b signiﬁcantly suppressed the
ﬁreﬂy luciferase activity of the reporter containing the
wild-type, but not the mutant binding site of the 30-UTR
(Figure 6A), indicating that miR-26 may suppress gene
expression through its binding sequences at the 30-UTR
of target genes. Further investigation showed that
miR-26a/b could also diminish endogenous expression
of both CDK6 and cyclin E1 proteins (Figure 6B).
Moreover, downregulation of miR-26a/b was statistically
correlated with overexpression of CDK6 and cyclin E1 in
HCC tissues (Figure 6C). These data suggest that CDK6
and cyclin E1 are direct targets of miR-26a/b.
The involvement of CDK6 and cyclin E1 in miR-26-
regulated G1/S transition was then addressed. Silencing
of either CDK6 or cyclin E1 (Figure 6B) led to the
arrest of the cell cycle in G1-phase (Figure 6D), which
was the phenocopy of the result of enhanced miR-26
expression, whereas overexpression of CDK6 and cyclin
E1 abrogated miR-26-induced G1-arrest (Figure 6E).
It is well known that CDK6, cyclin E1, cyclin D2 and
cyclin E2 initiate the phosphorylation of pRb, which in
turn, results in pRb inactivation and the release of E2F.
E2F consequently transactivates the genes required for
S-phase entry. Therefore, we explored whether miR-26
could attenuate these events. Introduction of miR-26
caused a prominent decrease of ppRb (Figure 7A),
whereas miR-26 inhibition enhanced the expression of
CDK6 and cyclin E1 and increased the level of ppRb in
siMyc-transfectants (Figure 7B). These results imply that
miR-26 may activate the pRb protein by suppressing
CDK6 and multiple G1-phase cyclins.
Interestingly, expression of CTDSP1/2/L signiﬁcantly
decreased the level of ppRb (Figure 7C, lanes 1 and 2),
and a synergistic repression was observed when CTDSP1/
2/L were co-expressed with miR-26a/b (Figure 7C).
Consistently, knockdown of CTDSP1/2/L increased the
amount of ppRb (Figure 7D, lanes 2 and 4), and the syn-
ergistic effect was also found when both miR-26a/b and
their host genes were inhibited (Figure 7D).
These ﬁndings indicate that miR-26a/b and their host
genes cooperate to activate pRb protein, and in turn,
block the G1/S transition.
Figure 5. miR-26a/b function synergistically with CTDSP1/2/L to block G1/S transition. (A) Effect of miR-26a/b and CTDSP1/2/L co-expression on
the cell cycle. The 95D cells were transfected with NC or miR-26a/b for 24h, followed by transfection with the control vector (EGFP) or the mixture
of the CTDSP1-, CTDSP2- and CTDSPL-expression vector. (B) Effect of miR-26a/b and CTDSP1/2/L inhibition on the cell cycle. HepG2 cells were
co-transfected with 20nM siMyc, a mixture of siCTDSP1/2/L (6.7nM each) and 200nM anti-miR-26. For (A and B), nocodazole was added 32h
after the last transfection, and the cells were cultured for an additional 16h before harvesting for FACS analysis. *P<0.05; **P<0.01; and
***P<0.001.
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Although 40% of all miRNAs are located within intronic
regions of protein-coding TUs (2), the functional associ-
ation between miRNAs and their host genes remains
unclear. In this study, we found that miR-26a/b were
expressed concomitantly with their host genes CTDSP1/
2/L in both physiological and pathological processes.
Moreover, miR-26a/b and CTDSP1/2/L synergistically
blocked the G1/S transition by activating the same
protein, pRb.
The pRb-pathway acts as a master checkpoint in cell
cycle progression. Cyclic phosphorylation and
dephosphorylation of the pRb protein control the entry
of cells into S-phase. Here, we found a synergistic effect of
miR-26a/b and CTDSP1/2/L in decreasing the ppRb level
and blocking the G1/S progression. Both miR-26a and
miR-26b reduced the amount of ppRb by repressing the
CDK and cyclins that mediate the phosphorylation of
pRb. On the other hand, CTDSP1/2/L may directly
dephosphorylate ppRb because CTDSP1/2/L possess
Figure 6. CDK6 and cyclin E1 are involved in miR-26-mediated G1-arrest. (A) miR-26a/b suppressed the activity of luciferase through its binding
sequences at the 30-UTR of target genes. MHCC-97L cells were co-transfected with miR-26a/b or NC, a ﬁreﬂy luciferase reporter containing
wild-type or mutant 30-UTR (indicated as Wt or Mut on the x-axis), and Renilla luciferase expressing constructs. The ﬁreﬂy luciferase activity of
each sample was normalized to the Renilla luciferase activity. (B) miR-26a/b, siCDK6 and siCCNE1 repressed endogenous CDK6 and cyclin E1
expression. Forty-eight hours after transfection with the indicated RNA duplex (50nM), endogenous mRNA and protein levels were assessed by
RT–PCR and western blot, respectively. b-actin and hPRT were used as internal controls. (C) miR-26a/b levels were inversely correlated with CDK6/
cyclin E1 expression in HCC tissues. Expression of CDK6 and cyclin E1 were analyzed by immunohistochemical staining, and the levels of mature
miR-26a/b were detected by qPCR. Statistical analysis was performed using Spearman’s correlation coefﬁcient. (D) Overexpression of miR-26a/b and
knockdown of either CDK6 or cyclin E1 increased the G1-population. (E) Expression of CDK6 and cyclin E1 attenuated miR-26b-induced
G1-arrest. The 95D cells were ﬁrst transfected with 20nM NC (negative control) or miR-26b for 24h, followed by transfection with the empty
pc3-gab vector (indicated as EGFP) or the mixture of pc3-gab-CDK6 and pc3-gab-CCNE1 vectors (Mix), which encoded the entire coding sequence
of the indicated gene, but lacked the 30-UTR. *P<0.05; **P<0.01; and ***P<0.001.
4622 Nucleic Acids Research, 2012,Vol.40, No. 10phosphatase activity (29–31). It is intriguing to ﬁnd that
miR-26a/b and their host genes regulate pRb phos-
phorylation through different molecular mechanisms.
The cooperation of miR-26 and CTDSP1/2/L in the
pRb pathway may provide a ‘double guarantee system’
for the activation of the pRb protein, which guards cells
from excessive proliferation. Our observations give new
insight into the elaborate control of G1/S transition and
suggest the existence of a single gene locus that harbors
two independent, but cooperating growth-suppressive
elements.
c-Myc is essential for progression from G0/G1 to
S-phase (32). It has been demonstrated that c-Myc acti-
vates the positive regulator of G1/S transition, including
cyclin D1, cyclin D2, cyclin E1, CDK4, CDC25A and
E2F, during cell cycle progression (32). Here, we showed
that c-Myc could downregulate both miR-26 and CTDSP
family members, which enhanced ppRb levels and ultim-
ately promoted the G1/S transition. Our ﬁndings disclose
a novel mechanism by which c-Myc promotes cell cycle
progression by suppressing one gene locus that carries
both miRNA and protein-coding gene.
The serum starvation–stimulation assay in primary
ﬁbroblasts and the two-thirds partial hepatectomy in
mice revealed the increased expression of miR-26a/b and
CTDSP1/2/L in quiescent cells and the downregulation of
both families during cell proliferation. Furthermore, the
levels of miR-26a/b and CTDSP1/2/L were reduced in
HCC tissues. These data suggest that miR-26a/b and
CTDSP1/2/L may keep ﬁbroblasts and hepatocytes in a
non-dividing state, and their deregulation may promote
malignant transformation. The underlying mechanism
responsible for the decreased expression of these two
families in HCC is still unknown. Notably, c-Myc activa-
tion is a common event in HCC (33). Ampliﬁcation of
chromosome 8q24, in which c-Myc is located, and
upregulation of c-Myc and its downstream target genes
are observed in viral and alcohol-related HCC (34).
Studies from animal models have also revealed that
c-Myc overexpression promotes HCC development (33).
Thus, abnormal c-Myc activation may represent an im-
portant mechanism underlying the downregulation of
miR-26a/b and CTDSP1/2/L. In addition, CTDSP1/
miR-26b is located at chromosome 2q35, a region that is
frequently deleted in human cancers, especially HCC (35).
We were also able to computationally map CpG islands in
the promoter regions (between  2000 and 600 bp) of
CTDSP1/2/L and miR-26a/b. Therefore, deletion and
promoter hypermethylation may also account for the
reduced expression of CTDSP1/2/L and miR-26a/b in
HCC.
CTDSP1, CTDSP2 and CTDSPL belong to a protein
family of small C-terminal domain (CTD) phosphatases,
also known as the SCP family. They can negatively
regulate RNA polymerase II (RNAPII) by dephos-
phorylating its CTD on Ser-5 in vitro (31), and also
function as transcriptional co-repressors that inhibit the
transcription of neuronal gene in non-neuronal cells (36).
Figure 7. miR-26a/b and CTDSP1/2/L block the G1/S transition by synergistically activating the pRb protein. (A) Effect of miR-26a/b on the
phosphorylation of the pRb protein. (B) Effect of anti-miR-26 on the levels of CDK6, cyclin E1 and ppRb in c-Myc-knockdown cells. HepG2 cells
were co-transfected with the indicated siRNA duplex (20nM) and miRNA inhibitor (200nM). (C) The synergistic effect of miR-26a/b and CTDSP1/
2/L on ppRb levels. The 95D cells were transfected with NC or miR-26a/b for 24h, followed by transfection with the control vector (EGFP) or the
mixture of the CTDSP1-, CTDSP2- and CTDSPL-expression vectors (CTDSP1/2/L). (D) The synergistic effect of anti-miR-26 and siCTDSP1/2/L on
ppRb levels in c-Myc-knockdown cells. HepG2 cells were co-transfected with 20nM siMyc, the mixture of siCTDSP1, siCTDSP2 and siCTDSPL
(6.7nM each) and 200nM miRNA inhibitor. For (A–D), 48h after the last transfection with the indicated RNA oligoribonucleotides or vectors, cells
were subjected to western blot analysis.+, 20nM of the indicated RNA duplex or 200nM miRNA inhibitor was transfected; + +, 40nM NC was
transfected. NC and anti-miR-C were used as negative controls for RNA duplexes and anti-miR-26, respectively. pRb, total pRb protein; ppRb,
Ser780-phosphorylated pRb; b-actin, internal control.
Nucleic Acids Research, 2012,Vol.40, No. 10 4623Growing evidence also suggests that CTDSP1/2/L act as
phosphatases of Smad1, Smad2/3 and snail (29,30). It has
been demonstrated that CTDSPL dephosphorylates the
ppRb protein and presumably regulates the cell cycle.
CTDSPL is homozygously deleted in  15% of cervical
carcinomas, and CTDSPL suppresses the ability of renal
carcinoma cells to form colonies in vitro and to develop
tumors in SCID mice (22). However, the effect of the
other two family members, CTDSP1 and CTDSP2, on
the cell cycle and tumorigenesis is still unknown. Here,
we showed that CTDSPL, CTDSP1 and CTDSP2
could block G1/S progression, and all CTDSP family
members were downregulated in HCC tissues, suggesting
that CTDSP1/2/L dysfunction may be involved in
hepatocarcinogenesis.
In summary, we disclosed the cooperative effect of
miR-26a/b and their host genes CTDSP1/2/L in the cell
cycle control and their potential implication in physio-
logical and pathological processes. Our ﬁndings highlight
the functional association of miR-26a/b and their host
genes, provide new insight into the regulatory network
of the cell cycle and open the possibility for future thera-
peutic intervention.
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